The CLEAR trial: Results of a large community-based study of metronidazole gel in rosacea

Cutis

Volumn 79, Issue 1, 2007, Pages 73-80

  Wolf Jr , John E ^a,c   Del Rosso, James Q ^b,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c Galderma

^d Managed Care and Professional Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FEMALE; FOLLOW UP; GEL; HOSPITALIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LEISURE; MALE; MULTICENTER STUDY; PATHOLOGY; PHASE 4 CLINICAL TRIAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SAFETY; SELF CONCEPT; SOCIAL BEHAVIOR; TELANGIECTASIA; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFECTIVE AGENTS; ERYTHEMA; FEMALE; FOLLOW-UP STUDIES; GELS; HUMANS; LEISURE ACTIVITIES; MALE; METRONIDAZOLE; PRURITUS; QUALITY OF LIFE; ROSACEA; SAFETY; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR; TELANGIECTASIS; TREATMENT OUTCOME;

EID: 33846889755     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Frampton JE, Wagstaff AJ. Azelaic acid 15% gel in the treatment of papulopustular rosacea. Am J Clin Dermatol. 2004;5:57-64.
2. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis. 2002;70:271-275.
3. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician. 2002;66:435-440.
4. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46:584-587.
5. Buechner SA. Rosacea: an update. Dermatology, 2005;210:100-108.
6. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 1987;21:346-351.
7. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3:489-496.
8. Pye RJ, Burton JL. Treatment of rosacea by metronidazole. Lancet. 1976;1:1211-1212.
9. Wolf JE Jr. The role of topical metronidazole in the treatment of rosacea. Cutis. 2004;73(suppl 1): 19-28.
10. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987;123:609-614.
11. Espagne E, Guillaume JC, Archimbaud A, et al. Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea [in French]. Ann Dermatol Venereol. 1993;120:129-133.
12. Gupta AK, Chaudhry M. Topical metronidazole for rosacea. Skin Therapy Lett. Jan 2002;7:1-3, 6.
13. Finlay AY, Khan OK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.